• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

TNGN:US

0.0900 USD 0.0079 9.62%

As of 10:07:57 ET on 08/27/2014.

Snapshot for Tengion Inc (TNGN)

Open: 0.0900 Day's Range: 0.0850 - 0.0900 Volume: 17,350
Previous Close: 0.0821 52wk Range: 0.0746 - 0.8000 1-Yr Rtn: -86.76%

Stock Chart for TNGN

No chart data available.
  • TNGN:US 0.0860
  • 1D
  • 1M
  • 1Y
0.0821
Interactive TNGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TNGN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.5200
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 2.06
Shares Outstanding (M) 25.05
30 Day Average Volume 111,336
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 12/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TNGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TNGN

Tengion Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. The Company currently creates functional neo-organs and neo-tissues using a patient's own cells, or autologous cells, in conjunction with its Organ Regeneration Platform.

John L MiclotPresident/CEOTimothy Bertram "Tim"Pres:Rsch & Dev/Chief Scientific Ofcr
A Brian DavisSenior VP:Finance/CFO/Secretary
More Company Profile & Key Executives for TNGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil